Table Graph
      published meta-analysis   sensitivity analysis   studies

IFN beta-1a in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsDarazam, 2021 (REV) 0.83 [0.44; 1.54] 0.83[0.44; 1.54]Darazam, 2021 (REV)10%168NAnot evaluable clinical improvementdetailed resultsDarazam, 2021 (REV) 0.73 [0.47; 1.13] 0.73[0.47; 1.13]Darazam, 2021 (REV)10%168NAnot evaluable clinical improvement (time to event analysis only)detailed resultsDarazam, 2021 (REV) 0.73 [0.47; 1.13] 0.73[0.47; 1.13]Darazam, 2021 (REV)10%168NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-05-02 00:41 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 881,904 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons